On December 11, 2019 PierianDx, the leading clinical genomics informatics company, reported that Intermountain Healthcare has selected the PierianDx Clinical Genomics Workstation to advance their precision medicine program, Intermountain Precision Genomics (Press release, PierianDx, DEC 11, 2019, View Source [SID1234552270]). Intermountain Healthcare will leverage PierianDx for next-generation sequencing (NGS) variant analysis, classification, and reporting services to assist in the identification of targeted therapies and potential clinical trial opportunities for cancer patients.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

PierianDx provides a SaaS platform, Clinical Genomics Workspace (CGW), the industry-leading clinical software for informatics, interpretation, and reporting of NGS data. By joining the PierianDx customer network, Intermountain Healthcare can access the genomic data within CGW’s knowledgebase, the most clinically robust database comprised of millions of biomedical findings driven by public and highly curated sources. Intermountain Healthcare joins a long list of other leading diagnostic labs and health systems using PierianDx.

"We are thrilled that Intermountain Healthcare has joined our rapidly expanding partner network," says Michael L. Sanderson, CEO of PierianDx. "Intermountain Healthcare is widely known as a leader in precision medicine and we look forward to continued collaboration opportunities."